Frank P. Cammisa Jr., MD

Industry Relationships

One of the goals of Hospital for Special Surgery (HSS) is to advance the science of orthopedic surgery, rheumatology, and related disciplines for the benefit of patients. Physicians at HSS may collaborate with outside companies for education, research and medical advances. HSS supports this collaboration in order to foster medical breakthroughs; however HSS also believes that these collaborations must be disclosed.

As part of the disclosure process, this website lists physician collaborations with outside companies if payments were received during the prior year, or if the HSS physician currently receives payment. The disclosures are provided by information provided by the physician and other sources and are updated regularly. Further information may be available on individual company websites.

Below are the healthcare industry relationships reported by Dr. Cammisa as of October 05, 2009.

• Centinel Spine (formerly Raymedica, LLC) - Corporate Medical Advisory Board, Consultant
• HealthPoint Capital (research-based private equity firm focused on orthopedic and dental devices) - Scientific Advisory Board
• HydroCision, Inc. - Consultant
• Ivy Healthcare Capital Partners I and II (private equity firm focused solely on the musculoskeletal and orthopedic sector of the healthcare industry) - Scientific Advisory Board
• K2 Medical, LLC - Scientific Advisory Board
• Mazor Surgical Technologies, LLC - Scientific Advisory Board
• NuVasive, Inc. - Consultant, receives royalties for design
• Paradigm Spine, LLC - Corporate Medical Advisory Board, Consultant
• Spinal Kinetics - Consultant
• Spinal Partners III - Medical Advisory Board
• Viscogliosi Brothers, LLC (non-publicly traded investment company) - Spine Advisory Board, Consultant

By disclosing the collaborations of HSS physicians with industry on this website, HSS and its physicians make this information available to their patients and the public, thus creating a transparent environment for those who are interested in this information. Further, HSS’ Conflicts of Interest Policy does not permit physicians to collect royalties on products developed by him/her that are used on patients at HSS.

Patients should feel free to ask their HSS physicians questions about these relationships.